Exchange: NASDAQ·Updated 07:59 PM EST

NAUT News

News
all
press releases
Nautilus Biotechnology (NASDAQ:NAUT) Share Price Breaks Below 200 Day Moving Average - Here's What Happened
Nautilus Biotechnology (NASDAQ:NAUT) Shares Cross Below 200 Day Moving Average - Here's Why...
MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Share Price Breaks Below 200 Day Moving Average - Here's What Happened
Nautilus Biotechnology (NASDAQ:NAUT) Shares Cross Below 200 Day Moving Average - Here's Why...
MarketBeat
More News
The names on today’s watchlist may look familiar, but the stories are moving. NeOnc Technologies Holdings (NASDAQ:NTHI) is approaching an important FDA discussion, XIAO-I Corporation (NASDAQ:AIXI) remains a high-volatility AI stock, and BIO-key International (NASDAQ:BKYI) is adding government customers in the Gulf. Meanwhile, Bolt Biotherapeutics (NASDAQ:BOLT) announced a major acquisition and financing package, Nautilus Biotechnology (NASDAQ:NAUT) is preparing to report earnings, and AI OKTO (NASDAQ:AIOK) declared a substantial special dividend. Across communications technology with ClearOne (NASDAQ:CLRO), staffing and recruiting with Robert Half (NYSE:RHI), and satellite cybersecurity with WISeSat.Space (NASDAQ: SAIQ).
24-7 Market News
Gainers Quantum-Si (NASDAQ:QSI) stock rose 30.3% to $1.59 during Friday's regular session. The company's market cap stands at $267.0 million. Nautilus Biotechnology (NASDAQ:NAUT) stock rose 26.09% to $2.29.read more...
Benzinga
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned commercialization timeline, with management emphasizing expanding early customer...
MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.12) earnings per share for the quarter, beating the consensus...
MarketBeat
Sentinel Trust Co. LBA purchased a new stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 750,000 shares of the company's stock, valued at approxi...
MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-28-nautilus-biotechnology-inc-stock...
MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 674,952 shares, an increase of 51.1% from the March 15th total of 446,652 shares. Approximately 0.9% of...
MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) executives outlined the company's strategy to unlock the power of the proteome and argued that better protein measurement tools could improve drug development...
MarketBeat

Advertisement|Remove ads.